Background: Chronic obstructive pulmonary disease (COPD) is a huge burden to the health care facility worldwide that is both substantial and increasing. Exacerbations of COPD have a negative impact on health status, rates of hospitalization and disease progression. However, there is still a lack of effective biomarkers...
Goutam Sen, Mushfiq Newaz Ahmed, Mir Mahmud et al.· Chest & Heart Journal· 0 citations
The 2MWT is a reliable, valid, and sensitive test for the assessment of functional status in patients with stable COPD and is practical, simple, quick, easy to administer, and well-tolerated by patients with stable COPD.
Sumya Zabin Sonia, Md Zahirul Islam, Golam Sarwar Liaquat Hossain Bhuiyan et al.· Chest & Heart Journal· 0 citations
Fever, cough, breathlessness, and fatigue were the most common symptoms of COVID-19 infection even 4 weeks after recovery and mean spirometric parameters and six-minute walk distance were reduced in patients with COVID-19 infection even 4 weeks after recovery.
M. A. Rahman, Shamim Ahmed, R. Chakrabortty et al.· Chest & Heart Journal· 0 citations
Elevated BUN/Albumin ratios may serve as a useful biomarker for identifying patients at higher risk for respiratory failure and may help guide early intervention in clinical practice.
Md Shahjahan Ali, Mahmud Rahim, Rezaul Haque et al.· Chest & Heart Journal· 0 citations
Significant exercise-induced desaturation correlated with COPD severity, supporting 15SCT as a useful tool for predicting severe airflow limitation in stable COPD patients.
Tasnuba Tahsin Tofa, Mahmud Rahim, Md Zahirul Islam et al.· Chest & Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.